SZSE Ticker: 300841

Chengdu Kanghua Biological Products Co., Ltd.

成都康华生物制品股份有限公司

康华生物

KANGHUA BIOLOGICAL

Listing Date: 2020-06-16

Board: GEM

Industry Classification: Manufacturing

Kanghua Bio: Wu Wennian has accumulated about 17,500 shares in the company_Oriental Fortune Net

Post date May 16, 2022 — 21:19 Post Lock

Kanghua Biotech (300841.SZ) has accumulated 17,500 shares increased by executive Wu Wennian

Post date May 16, 2022 — 21:16 Post Lock

Kanghua Biotechnology (300841.SZ) has accumulated 17,500 shares increased by executive Wu Wennian

Post date May 16, 2022 — 21:16 Post Lock

The biological vaccine sector moved up

Post date May 12, 2022 — 13:04 Post Lock

At the end of the first quarter, QFII held a stock market value of more than 180 billion 10 shares, accounting for more than 10% of the QFII_Sina Finance_Sina.com

Post date May 11, 2022 — 08:30 Post Lock

At the end of the first quarter, QFII held a stock market value of more than 180 billion and 10 shares accounted for more than 10% of the holdings.

Post date May 11, 2022 — 05:55 Post Lock

Foreign capital has won nearly 33% of the tradable shares, and the well-known QFII has bought this heavily-held stock to become the largest tradable shareholder! These QFII heavyweight stocks have high growth, low valuation and high drawdown

Post date May 10, 2022 — 19:30 Post Lock

Investment hedging guide: Global chip market growth slowed down in March, two directors of Industrial Bank resigned, and chairman of Zhongqingbao resigned

Post date May 9, 2022 — 08:56 Post Lock

Kanghua Biotechnology (300841.SZ): It is proposed to require relevant shareholders to repurchase the shares of Guangxi Aipet held by the company_Individual Stock Information_Market Gold Online

Post date May 8, 2022 — 22:17 Post Lock

Kanghua Biotechnology (300841): Selling Equity and Exiting Joint Investment Enterprises of Related Parties and Related Transactions CFi.CN Zhongcai.com

Post date May 8, 2022 — 18:46 Post Lock

Kanghua Biotechnology (300841): Resolution of the sixth meeting of the second board of supervisors CFi.CN

Post date May 8, 2022 — 18:46 Post Lock

Kanghua Bio (300841): Minsheng Securities Co., Ltd.'s special inspection opinion on Chengdu Kanghua Biological Products Co., Ltd.'s sale of equity to exit the joint investment enterprise of related parties and related transactions- CFi.CN Zhongcai Network

Post date May 8, 2022 — 18:46 Post Lock

Kanghua Biotechnology (300841): Resolution of the seventh meeting of the second board of directors- CFi.CN Zhongcai Network

Post date May 8, 2022 — 18:46 Post Lock

Kanghua Bio (300841.SZ) core technical staff Zhao Zhipeng leaves

Post date May 6, 2022 — 20:36 Post Lock

Yingke Capital Lai Manying was awarded the "Best Young Investor in China's Equity Investment Industry in 2021"

Post date May 6, 2022 — 11:46 Post Lock

The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of the results are good news, and half of the stocks have a price-earnings ratio of less than 30 times. Rongyi Finance and Economics

Post date May 5, 2022 — 06:19 Post Lock

Beishang funds will return to A shares in April! Foreign investors' heavy holdings in the first quarter are exposed (with a list) Rongyi Finance_Providing domestic financial information

Post date May 5, 2022 — 05:21 Post Lock

The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 3 – yqqlm

Post date May 4, 2022 — 02:56 Post Lock

The world's first inactivated vaccine of Omicron strain is launched! The research and development intensity of vaccine stocks is 3.86 times that of A-shares as a whole, more than 70% of them report good results, and half of the stocks have a price-earnings ratio of less than 30 times.

Post date May 3, 2022 — 20:41 Post Lock

Beishang funds returned to A-shares in April, and foreign investors with heavy holdings in the first quarter were exposed – yqqlm

Post date May 3, 2022 — 19:57 Post Lock

Want to see more data? Registered subscribers can see all the data.